Omada-based healthtech company Omada Health has raised $50m in a funding round led by Cigna and featuring participation from new investors Civilization Ventures and Sanofi Genzyme BioVentures. Cigna is also set to expand its commercial partnership with Omada, whose digital health app adopts a behavioural change orientation in the treatment of prediabetic patients, aiming to prevent them from developing full-scale Type 2 diabetes. Cigna's previous entry into the healthcare sector, an investment in Audax Health Solutions, ended acrimoniously after UnitedHealth Group’s health IT unit, Optum, took a majority interest.
San Francisco-based healthtech company Omada Health has raised $50m in a funding round led by Cigna and featuring participation from new investors Civilization Ventures and Sanofi Genzyme BioVentures. Cigna is also set to expand its commercial partnership with Omada, whose digital health app adopts a behavioural change orientation in the treatment of prediabetic patients, aiming to prevent them from developing full-scale Type 2 diabetes. Cigna's previous entry into the healthcare sector, an investment in Audax Health Solutions, ended acrimoniously after UnitedHealth Group’s health IT unit, Optum, took a majority interest.